Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention

por Glaubius, Robert L., Parikh, Urvi M., Hood, Greg, Penrose, Kerri J., Bendavid, Eran, Mellors, John W., Abbas, Ume L.
Publicado 2016

Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost‐effectiveness

por Glaubius, Robert, Ding, Yajun, Penrose, Kerri J, Hood, Greg, Engquist, Erik, Mellors, John W, Parikh, Urvi M, Abbas, Ume L
Publicado 2019

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa

por Penrose, Kerri J, Brumme, Chanson J, Scoulos-Hanson, Maritsa, Hamanishi, Kristen, Gordon, Kelley, Viana, Raquel V, Wallis, Carole L, Harrigan, P Richard, Mellors, John W, Parikh, Urvi M
Publicado 2018

HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial

por Parikh, Urvi M., Penrose, Kerri J., Heaps, Amy L., Halvas, Elias K., Goetz, B. Jay, Gordon, Kelley C., Hardesty, Russell, Sethi, Rahil, Schwarzmann, William, Szydlo, Daniel W., Husnik, Marla J., Chandran, Uma, Palanee‐Phillips, Thesla, Baeten, Jared M., Mellors, John W.
Publicado 2021